Hypertension is an easily diagnosed and eminently modifiable risk factor for the development of all clinical manifestations of atherosclerosis. Despite the availability of a simple, non-invasive, and rather accurate method of measuring blood pressure (BP), and overwhelming evidence that reducing BP effectively prevents cardiovascular events, hypertension at the population level is not managed optimally. In 1997/ 1998 and 2000/2001, two surveys for cardiovascular risk factors were conducted in nine districts of the Czech Republic, involving a 1% population random sample aged 25-64 years in each district. In concordance with the MONICA Project, the present study confirms a high prevalence of hypertension in the Czech population, detecting an increase in prevalence for the male population over a period of 3 years (males from 38.8 in
Introduction
Cardiovascular disease is the major cause of death in the Czech Republic, accounting for 53.4% of total mortality (males: 48.2%; females: 58.6% in 2000). Most of the Central and East European countries have very high rates of cardiovascular mortality. While there has been a downward trend in Northern and Western European countries since 1970, large increases were observed in Central and East European countries. 1 In the Czech Republic, unlike the other postcommunist countries, there has been a significant decrease in total and cardiovascular mortality since 1984, resulting in a substantial increase in life expectancy. 2 Hypertension is a well-established risk factor for the development of all clinical manifestations of atherosclerosis. Elevated blood pressure (BP) is a common and powerful predisposing factor for the development of coronary heart disease, stroke, peripheral arterial disease, and heart failure. 3 Randomised clinical trials of lowering BP using different drugs have convincingly shown that the risks associated with rising BP can be substantially reduced, particularly for stroke, and also for coronary heart disease and heart failure.
Findings from the WHO MONItoring trends and determinants in CArdiovascular diseases (MONICA) Project showed a remarkably higher prevalence of hypertension in Eastern Europe, and virtually no difference in the rates of controlled hypertension among Eastern and Western populations. 4 As part of the MONICA Project, there were three cross-sectional surveys for cardiovascular risk factors including hypertension conducted in the Czech Republic in 1985, 1988, and 1992 . These surveys were carried out in six, mostly rural districts (Praha-vý chod, Benešov, Pardubice, Chrudim, Cheb, and Jindřichů v Hradec), evaluated as a single centre. In order to obtain recent data on a more representative sample of the Czech population, similar crosssectional surveys for cardiovascular risk factors were organised in nine districts (six of them participating previously in the MONICA Project plus an additional three) in 1997/1998 and 2000/ 2001. By increasing the sample size and expanding the surveyed area, the study can be considered a truly nationwide one. Its results on BP levels and on the prevalence, awareness, treatment, and control of hypertension are presented in this paper.
Methods
In 1997/1998 and 2000/2001, two surveys for cardiovascular risk factors were conducted in nine districts of the Czech Republic, involving a 1% population random sample aged 25-64 years in each district. Selection (stratified by age, sex, and community size) was made from the General Health Insurance Company register keeping, by law, a list of all those insured. Individuals were contacted by mail, followed by a visit to a special screening clinic in each district. The overall respondence rates were 64.5 and 63% for the respective two surveys, without any major regional fluctuations. The respondence rate never decreased below 60% in any district. Six of the nine districts participated previously in the WHO MONICA Project, and they were mostly rural districts. The main reason for including another three districts (Kroměříž, Litoměřice, Plzeň město) was to obtain a more representative population sample with respect to the geographic location and also, involving one large city population (Plzeň ). Altogether, these nine districts cover 11.2% of the total area of the Czech Republic inhabited by 9.9% of the country's total population. The examination consisted of a physician-completed questionnaire, which included questions whether, at any time in the past, the patient had received treatment for high BP or had hypertension diagnosed, and whether they were currently taking antihypertensive medication. The names of currently prescribed medications were recorded and validated against medication containers when possible.
Height and body weight were measured with participants standing without shoes and heavy outer garments. Body mass index (BMI) was calculated as weight divided by height squared (kg/m 2 ) as a measure of relative weight. Obesity was defined as BMI X30 kg/m 2 for both sexes. BP was measured on the right arm with the subject in the sitting position after at least 5 min at rest.
Standard mercury sphygmomanometers (Baumanometer, New York, USA), and correctly sized cuffs were used. The participant's right arm was supported at the heart level. The maximum inflation level was determined before the actual measurement. The first and fifth Korotkoff sounds were recorded for systolic and diastolic BP, respectively, and for sounds continuing to 0 mmHg, the fourth Korotkoff sound was used. Heart rate was also determined. BP values were recorded to the nearest 2 mmHg. Three consecutive BP measurements were obtained. The mean value of the second and third readings was used in this analysis.
In this study, hypertension was defined as a mean systolic BP (SBP) X140 mmHg, and/or a mean diastolic BP (DBP) X90 mmHg, or current treatment with antihypertensive drugs. Awareness of hypertension was defined as a subject having reported a previous diagnosis of hypertension or current usage of antihypertensive medication. Treatment of hypertension was defined as current use of a prescribed medication affecting BP. Hypertension control was defined as having a SBP o140 mmHg and a DBP o90 mmHg.
Stages of hypertension were defined, according to the JNC VI, 5 as follows (in mmHg): (1) 140-159 (systolic) or 90-99 (diastolic); (2) 160-179 (systolic) or 100-109 (diastolic); and (3) X180 (systolic) or X110 (diastolic).
Using BMDP statistical software, analysis was undertaken separately for males and females. Discrete variables were analysed by log linear models (three-way contingency tables) and continuous ones by two-way ANOVA and Bonferroni significance levels.
Results
Overall, we had valid BP measurements, body weight, and height for 6528 adults who had provided details regarding their awareness of and medication for high BP. Sample sizes and respondence rates for males and females of each survey are given in Table 1 . BMI and obesity rose with age in both sexes (Tables 2 and 3 ). In the male population, there was a significant increase in BMI (27.573 Tables 6 and 7) .
Prevalence of hypertension
Prevalence of hypertension significantly increased with age in both sexes, being much higher in younger males than females. No gender-related differences in the prevalence of hypertension were observed in the oldest age group.
Despite no major changes in the population mean BP, there is an increase in the prevalence of hypertension in the male population between the two surveys (from 38.8 to 42.3% for the entire examined population; Po0.05).
Awareness of hypertension
Awareness of hypertension increased with age in both sexes. It was slightly higher in females. The total surveyed male population showed an increase in the awareness of hypertension (from 57.3 to 63.0%; Po0.05) over the 3-year period. Epidemiology of hypertension in the Czech population R Cífková et al
Treatment of hypertension
Generally, less than half of all male hypertensives were receiving treatment (Table 6) , and the lowest rate of treatment was among men aged less than 35 years. There was an increase in the proportion of male individuals treated for hypertension for the period from 1997/1998 to 2000/2001 (from 38.9% to 44.3%; Po0.05). No change was found within the female population generally showing a higher proportion of patients being on medication for hypertension (approx. 60%, Table 7 ). An analysis of antihypertensive medication in both surveys is presented in Table 8 . In males, there is an increase in the proportion of patients treated by a combination of 3 and more drugs, whereas there is no such change in the female population. The major problem is still a rather low proportion of individuals treated by a combination of drugs. In the last survey, there were 54% of males and 51% of females treated by a combination of antihypertensive drugs.
Control of hypertension
Unfortunately, control of hypertension (BP o140/ 90 mmHg) did not change in either sex between the two surveys. Generally, the rates for control of hypertension were better for the female population.
In the female population, it was easier to achieve control of diastolic BP (DBP o90 mmHg) than that of systolic BP (SBP o140 mmHg). In both surveys, the goal DBP in females was achieved in 55%, whereas the goal SBP was achieved in only less than 40% (39.9 and 39.1%, respectively, NS). Both the goal SBP and DBP were achieved in 25%. 
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A similar development in the control of hypertension was seen in the male population showing no significant changes between the two surveys (14.2 and 16.4%, respectively, NS). There is no significant change in SBP control and there is a slight improvement in DBP control, particularly in males aged 55-64 years, resulting in an improvement of DBP control in the entire male population (32.7 and 43.3%, respectively, Po 0.01).
Stages of hypertension
In 1997/1998, there were 512 (32.3%) male and 355 (21.3%) female subjects with BPX 140/90 mmHg in the surveyed population ( Table 9 ). The majority of them (71.3% of males and 75.8% of females) were in Stage 1 hypertension, and 27.7% of male and 23.9% of female subjects were in Stage 2. Fortunately, the prevalence of Stage 3 hypertension was very low in both sexes (1.0% of males and 0.3% of females).
At the last screening in 2000/2001, there was a decrease in Stage 2 hypertension, and an increase in Stage 1 hypertension in the male population.
Discussion
These data provide the first nationwide summary on the Czech population mean BP, prevalence, awareness, treatment, and control of hypertension over the period from 1997/1998 to 2000/2001. The respondence rate did not decrease below 60% in any of the districts involved, so our results can be considered to be representative for the Czech population. This is supported by an analysis of mailed questionnaires confirming approximately the same level of education between respondents and nonrespondents. There is an association between the prevalence of cardiovascular risk factors and the level of education, 6 which was also confirmed in our population. 7 Our study found a high population mean of BMI and increasing BMI and prevalence of obesity in the male population. The relationship between hypertension and obesity is well established: BP increases with increasing body weight, and the incidence of hypertension among the obese approaches 50%. 8 The WHO MONICA Project conducted in 38 populations aged 35-64 years from 21 countries found, at the final screening (performed 1989-1996), a higher mean BMI in East European countries than the mean of all participating countries (males . Czech males ranked first among East Europeans, whereas Czech females lagged behind those of East Germany, Poland, and Novosibirsk (Russia). 9 The mean BMI of the Czech general population is close to the values often reported in patients included in large clinical trials in hypertension.
Like the mean BMI in Eastern Europe, a mean systolic BP in East European countries higher than the mean of all 38 populations (133 mmHg for males) was reported by the MONICA Project. 10 The highest male population mean was seen in former East Germany (141 mmHg), followed by former Czechoslovakia and Lithuania (both 137 mmHg). A similar pattern was found for females, again with the highest values reported in East Germany, Novosibirsk, and Yugoslavia (137 mmHg in all). Just for an approximate comparison, we calculated the mean of the first and second readings of our population aged 35-64 (ie, excluding the youngest age group of 25-34) years surveyed in 1997/1998 and 2000/2001. The respective means for SBP were 132 mmHg for males at both surveys, and 126 and 127 mmHg for females. The message of this approximate comparison is that (provided no substantial changes have occurred in the populations surveyed in the meantime) Czech males came from the second top position down to the mean and, similarly, Czech females moved from one of the highest positions to levels reported from Sweden and Italy (Brianza) being lower than the mean of all populations.
Our study confirmed a high prevalence of hypertension in both sexes affecting 42.3% of the male, and 31.3% of the female population in the last survey. It is obvious that inappropriate diet and physical inactivity contribute substantially to the high prevalence of obesity and hypertension. Sodium intake contributes to differences in blood pressure between populations and to the increase in BP with age.
11 Meta-analyses from controlled trials have consistently shown that blood pressure decreases with sodium restriction, although estimates of the size of the fall vary. [12] [13] [14] In the TONE study, 15 a decrease in sodium intake of about 40 mmol/day reduced requirements for antihypertensive drugs, with further improvement when weight loss and sodium restriction were combined. A reduced sodium intake adds to the substantial BPlowering effects of a diet (DASH combination diet) which focuses on fruit, vegetables, low-fat dairy products, whole grains, poultry, fish, and nuts. Proposals for population-wide reductions in salt intake have been controversial, but new evidence is strongly supportive of such a strategy. 16 Both the 1999 WHO-ISH guidelines for the management of hypertension 17 and JNC VI 5 suggest an intake of sodium chloride of less than 6 g/day. There is widespread consensus that diets rich in a variety of fruit and vegetables are protective against a wide range of chronic disease including cardiovascular disease. Several international bodies have proposed an average population goal of more than 400 g of fruit and vegetables per day. Data on food supply suggest that, in most countries in Europe including the Czech Republic, supplies of fruit and vegetables are insufficient to meet the more than 400 g/day 18 There is also a high consumption of alcohol, particularly beer, in the Czech population. There has been a rather stable annual per capita consumption of 160-161 l of beer since 1997! 2 In drinking populations, alcohol consumption is statistically second only to obesity as a major factor predisposing to hypertension. 19 The effect of alcohol on BP appears to increase linearly with increasing levels of consumption. 20, 21 People who drink three or more standard drinks a day have a two-to three-fold increase in the prevalence of mild hypertension compared with those who drink up to one drink a day. The effect of alcohol on BP is seen in all major ethnic groups, in both men and women, and with all types of alcohol beverages. 22 The effect appears to be greater with ageing, but has been described in adolescents. The effect may be greater with smokers, and is additive to the effects of obesity. It is worthwhile noting that there is also a very high prevalence of smoking in the Czech population, being 33.8 and 23.9% for males and females, respectively. 23 Drinking alcohol can increase antihypertensive drug requirements. Drinkers are more likely to present with resistant hypertension owing to poor compliance with drug therapy.
The prevalence of hypertension also depends on the number of visits and number of BP readings taken on each occasion. Unfortunately, similar to the WHO MONICA Project, the protocol included only one visit to the screening centre. To overcome this limitation, we performed three BP readings ignoring the first one and working only with the mean of the second and third readings. However, as BP was determined on one visit only, the prevalence of hypertension is most likely to be overestimated, usually by one-third in those hypertensives who are not on antihypertensive treatment yet. This may also adversely affect control of hypertension.
In 1972, Wilber and Barrow 24 published their classic paper of a community control of hypertension in which the term 'rule of halves' was introduced for the first time. According to this rule, only half of the hypertensive subjects are detected, and half of those who are detected are under antihypertensive drug treatment, of whom only half have their BP controlled adequately. These results demonstrating the suboptimal control of hypertension at the population level were soon confirmed in population surveys also in other parts of the world. 25, 26 These findings were adopted as the basis for many population-based hypertension control programmes starting in the early 1970s. The main objectives of these programmes were early detection and effective drug treatment of hypertension. Since the implementation of these populationbased programmes, some improvement in hypertension awareness, treatment and control has been achieved.
Awareness of hypertension in our population is, on the other hand, comparable with the latest US data. 27 However, there is no doubt that the fact that one-third of the population is not aware of hypertension and, consequently, not treated, contributes to the unsatisfactory overall control of hypertension. In a review by Marques-Vidal and Tuomilehto, 28 24 population surveys of hypertension awareness, treatment, and control published since 1983 were assessed. In males, the rates for hypertension awareness among hypertensive individuals varied from 23 to 93%. The corresponding figures in women were from 28 to 97%.
Treatment of hypertension increased in the male population from 38.9 to 44.3% (Po0.05) over the period from 1997/1998 to 2000/2001, and is still inadequately low in both sexes. Another problem is that those who are already on medication for high BP are not achieving the target value. Worldwide, the results of surveys of BP control in populations show suboptimal hypertension control. Control of hypertension defined as BPo140/90 mmHg varies between 10 and 30% in developed countries, and is much lower in developing countries. 29 Interestingly, in concordance with the WHO MONICA Project, our rates of control of hypertension are fully comparable with those of Western developed countries. In fact, we are closest to the situation in Canada in this respect. 30 Similar to large clinical trials, we found better control of DBP in the female population. The difference in achieving the goal for SBP or DBP for the male population was less remarkable. A recently published descriptive survey study by Oliveria et al 31 found that physicians do not treat hypertension more aggressively because they are willing to accept an elevated SBP in their patients. This has an important impact on public health because of the positive association between SBP and cardiovascular disease. 32, 33 The low rate of using combination therapy is another reason contributing to the suboptimal control of hypertension in the Czech population. The HOT study, 34 in which 18 790 hypertensive patients from 26 countries were enroled and randomised to one of three DBP goals (o90, o85, and o80 mmHg), clearly showed that two-thirds up to three quarters of the patients needed a combination of antihypertensive drugs. Similar to population data, Fagard et al 35 found that 50% of treated patients received monotherapy, a drug treatment that is not expected to control BP adequately in more than 40% of patients. The reason why primary care physicians do not use more antihypertensive drugs is not clear. It is possible that physicians are reluctant to add new drugs because it would enhance the complexity of the regimen and thereby promote nonadherence. This attitude is quite common in elderly patients with several concomitant diseases. Patients' compliance to drug therapy has been recognised as one of the major reasons why antihypertensive therapy fails. 5, 36 The management of hypertension in the community is a public health problem. In the Czech population, there are only less than 20% of hypertensive patients having adequate BP control. This has the potential to make a significant impact on the morbidity and mortality associated with cardiovascular disease and stroke. In most of the populations, there is a greater success rate in case detection, treatment, and control of hypertension in women. The possible explanation for a sex difference includes a higher frequency of contact with general practitioners by women and their better compliance with treatment.
In conclusion, the present study confirms a high prevalence of hypertension in a representative population sample of the Czech Republic in both sexes, detecting an increase in the prevalence for the male population over a period of 3 years (1997/1998; 38.8%, and 2000/2001; 42.3%; Po0.05). Within the same period, there is also an increase in the awareness of hypertension in males (from 57.3 to 63.0%; Po0.05). Also, the number of male individuals treated by antihypertensive drugs increased significantly. Unfortunately, there is no improvement in the control of hypertension, which is still suboptimal.
